Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

This study has been terminated.
(Slow accrual)
Information provided by (Responsible Party):
National Cancer Centre, Singapore Identifier:
First received: June 13, 2007
Last updated: September 22, 2015
Last verified: September 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)